Metabolic effect of the long-acting reversible contraceptive method (implant) compared to combined oral contraceptive in young women with type 1 diabetes
Latest Information Update: 01 Feb 2024
Price :
$35 *
At a glance
- Drugs Ethinylestradiol/desogestrel (Primary) ; Etonogestrel (Primary)
- Indications Pregnancy
- Focus Pharmacodynamics
- 30 Apr 2021 Status changed from active, no longer recruiting to completed.
- 29 Jun 2017 New trial record
- 27 Jun 2017 Status changed from not yet recruiting to recruiting.